Freshness note: This analysis was last updated 29 days ago. Fast-moving policy claims can change quickly, so check for newer official updates before relying on this verdict.
“RFK Jr. broke promises made during his Senate confirmation hearing to become Health Secretary”
Summary
Robert F. Kennedy Jr. made several statements during his February 2025 Senate confirmation hearing for Health and Human Services Secretary regarding vaccines, regulatory approaches, and public health policies. Some reporting suggests his actions as Secretary have diverged from testimony statements, though the extent and significance of these differences depend on interpretation of his original commitments and the timeframe considered.
Primary Sources
Official transcript of Kennedy's confirmation hearing before the Senate Health, Education, Labor and Pensions Committee in February 2025
Fact-checking analysis examining statements Kennedy made during confirmation and subsequent actions as HHS Secretary
Reporting on actions taken by Kennedy's HHS team regarding vaccine policy and industry regulation
Official Senate record of Kennedy's confirmation vote as HHS Secretary
Evidence Supporting the Claim
- During confirmation hearings, Kennedy stated he would not remove vaccines from the market, but subsequent HHS actions have included reviews of vaccine approval processes that critics characterize as threatening vaccine availability
- Kennedy testified that he supports vaccine choice rather than vaccine bans, while later policy directives have reportedly affected vaccine distribution programs
- Reporting indicates that Kennedy's HHS has taken regulatory actions regarding the pharmaceutical industry that differ in scope or approach from commitments described during testimony
Evidence Against / Context
- Kennedy's confirmation testimony emphasized vaccine safety research and transparency rather than maintaining all existing policies unchanged, which could encompass his subsequent actions
- The timeframe between confirmation and alleged promise-breaking is relatively short, and some reported actions may represent ongoing policy review rather than final decisions
- Distinguishing between breaking explicit promises versus pursuing policies consistent with stated principles but unexpected by some senators requires examination of specific testimony language and context
- Some actions characterized as breaking promises may reflect interpretations of his general policy direction rather than violations of specific commitments made under oath
Timeline
Robert F. Kennedy Jr. testifies before Senate HELP Committee for confirmation as HHS Secretary
Senate confirms Kennedy as Health and Human Services Secretary
Kennedy begins implementing policy changes at HHS, including reviews of vaccine programs
Media reports emerge characterizing certain HHS actions as departing from confirmation hearing statements
What This Means
Structured interpretation — not opinion
Key takeaway 1
Confirmation hearing testimony represents statements made to secure Senate approval, and tracking adherence requires comparing specific sworn statements to subsequent policy actions
Key takeaway 2
The characterization of whether promises were broken depends on whether Kennedy's statements are interpreted as specific commitments or general policy principles, and whether his actions as Secretary fall within the scope of those statements
Key takeaway 3
Cabinet officials often face scrutiny regarding consistency between confirmation testimony and subsequent actions, particularly on controversial policy areas where senators seek assurances
Key takeaway 4
Evaluating this claim requires distinguishing between actions that directly contradict specific commitments versus actions that surprise observers but remain consistent with the official's stated philosophy or interpreted mandate
Related Claims in health
“The FDA was changing leucovorin's label because it could help 'hundreds of thousands' of children with autism”
FDA Commissioner Marty Makary announced in September 2025 that the agency would change leucovorin's label to reflect potential benefits for some children with autism and cerebral folate deficiency. However, the FDA later clarified the label change applied to a rare subset of patients with a specific metabolic condition, not hundreds of thousands of children, and the agency disputed characterizations that overstated the scope of the change.
“The Trump administration enacted a 6-month moratorium on Minnesota Medicaid payments”
On February 27, 2026, the Trump administration implemented a six-month moratorium on federal Medicaid payments to Minnesota through the Centers for Medicare and Medicaid Services. The action was taken in response to Minnesota's policies regarding undocumented immigrants' access to state healthcare programs, which federal officials characterized as violations of federal law.
“90% of health care spending treats chronic disease”
The claim that 90% of healthcare spending treats chronic disease is an overstatement of the actual figures. Federal health agencies report that chronic diseases account for approximately 75-90% of healthcare spending, with the most commonly cited figure from the Centers for Disease Control and Prevention being 90% of the nation's $4.5 trillion in annual healthcare expenditures, though this appears to include broadly defined chronic conditions and may represent an upper-bound estimate.